8 results
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
class is still going ... initiating an ARB ... Receptor #Blockers #ARB ... #Conversion #Table ... #Dosing #Pharmacology
Angiotensin II Receptor Blocker (ARB) - Comparable Dose Chart 
 - Valsartan (Diovan®) 40 mg daily
Receptor Blocker (ARB ... 20 mg daily #ARB ... #Equivalent #Conversion ... #Dosing #Doseage ... #Table #AngiotensinII
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
If patient is stable ... Buprenorphine Dosing ... sublingual (SL) are ... chronic pain split dosing ... Treatment #Algorithm #Addiction
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
antigen, leading to complement ... blood types or during ... Complement activation ... Hypersensitivity #Types #Classification ... Diagnosis #Reactions #Table
Alcohol Use Disorder - Maintenance Treatment
Naltrexone (first line) - First line for most people without contraindications
contraindications - Dosing ... liver disease - Dosing ... also smokers - Dosing ... #pharmacology #table ... #addiction
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison Table ... Dosing usually begins ... common side effects are ... #UseDisorder #Addiction
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
RECEPTOR ANTAGONIST (ARB ... ) DOSING: TOOL ... #ARB #AngiotensinII ... #Pharmacology #Conversion ... Switching #Equivalent #Table
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
ANA, anti-Smith Ab ... , low complements ... Skin Disease Classification ... pancreatitis, protein-losing ... RNP antibodies, Complement